2025 Future Summit by Mölnlycke Health Care
Smarter incision care and partnerships are key to enhanced clinical practise and improved patient outcomes.
How can smarter incision care become a frontline defence against healthcare acquired infections? The recent 2025 Future Summit, arranged by Mölnlycke Health Care, highlighted that innovation, education and partnerships are essential to enhancing clinical practice and empowering healthcare professionals to improve post-operative patient outcomes.
The Future Summit held in the Netherlands on 6-7 October gathered over 130 international healthcare professionals from vascular, orthopaedic, general, and plastic surgery specialties.
“At Mölnlycke, we believe that education is a cornerstone of progress, and we were thrilled to bring together such a diverse and accomplished group of experts. It was inspiring to hear how important incisions are for surgeons; how protecting that incision is protecting the hours of work they have put in underneath it,” says Emma Wright, Chief Medical Officer at Mölnlycke Health Care.
Presided over by renowned experts Professor Javad Parvizi and Mr. Ibby Younis, the Future Summit provided a platform to explore cutting-edge advancements, share best practices, and foster interdisciplinary collaboration in wound care and surgical excellence.
A key focus was reducing Surgical Site Infections (SSIs), which remain a significant challenge in post-operative care. Also, undisturbed wound healing versus more frequent dressing changes is an issue that divides the medical profession.
Daniel Chaverri, Orthopaedic Surgeon and President of the Spanish Society of Wounds, agrees.
“The less we manipulate the wound, the better is the chance to avoid infections and other complications. Normally, we put the first dressing on in the operating room and change it after seven days,” he explains.
What can Mölnlycke do to improve the situation?
“Clinicians need a broad wound care portfolio to match the wide variety of patients and procedures they manage. It is our job to help support change by demonstrating the significant value our innovative solutions, such as Avance Solo, Mepilex Border Post-Op and Granudacyn, bring to clinical protocols and patient outcomes,” Nick Rothwell explains.
Protecting patients and clinicians from healthcare acquired conditions such as infections and pressure ulcers is at the very core of Mölnlycke’s offering and a cornerstone of sustainable healthcare delivery. Every infection, injury, or complication adds pressure—both in terms of cost and time—to overstretched systems and puts patients and healthcare professionals at risk. By empowering clinicians with the latest evidence and practical knowledge, Mölnlycke helps prevent incidents that negatively impact patients’ quality of life, reduce variation in care, and support more sustainable healthcare systems.
Learn more about Mölnlycke Health Care’s Wound Care portfolio here.
Latest news
Read all news-
New leaders appointed for Mölnlycke Health Care
Gothenburg, Sweden. 3 November 2026. Mölnlycke® announces the appointment of Anders Andersson as Chief Executive Officer (CEO) of Mölnlycke Health Care and Fredrik Wallefors as President of Surgical, effective 1 January 2027.
-
Mölnlycke Health Care announces new partnership with DEBRA International to help advance wound care for the EB community
Mölnlycke is partnering with DEBRA International, the world’s leading epidermolysis bullosa (EB) patient advocacy network, to deepen understanding of the needs of people living with EB and help advance wound care for the global EB community.
-
Mölnlycke and AROA partner to expand access to Endoform in the US
Mölnlycke Health Care has entered an exclusive agreement with AROATM to co-promote EndoformTM in the United States in post-acute settings, effective 16 October 2026.
-
Martin Ma joins Mölnlycke Zhende as General Manager
In this role, Martin will lead the joint venture's operations and growth strategy in China, with responsibility for commercial execution, organisational leadership, governance and delivery of growth ambitions in one of the world's largest wound care markets.
-
Mölnlycke launches MyFit™ by Biogel® to bring more inclusive sizing to surgical gloves
-
Mölnlycke joins ALPS as Gold Strategic Partner to advance limb preservation
Mölnlycke has joined the American Limb Preservation Society (ALPS) as an official Gold Strategic Partner, reinforcing a shared commitment to improving outcomes for patients at risk of amputation due to diabetic foot complications.
-
New consensus document highlights need to address post-operative blistering to improve patient outcomes
At Mölnlycke Health Care, we work alongside clinicians, researchers and healthcare experts to advance evidence-based care and help raise standards for post-operative care.
-
From pressure to potential: new report reveals opportunity to increase healthcare capacity
Gothenburg, Sweden. 21 September 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, today announces the launch of The Hidden Capacity Report, a new international report revealing significant opportunities to expand day surgery and help healthcare systems improve efficiency, increase surgical throughput and enhance patient outcomes.
-
Mölnlycke to separate its surgical solutions business into a standalone company
Gothenburg, Sweden. 16 September 2026. Mölnlycke®, a global leader in MedTech, announces its intention to separate its Operating Room Solutions (ORS) and Gloves businesses into a new standalone company (referred to here as “Mölnlycke Surgical”). The separation is intended to create conditions for both Mölnlycke and Mölnlycke Surgical to reach their full potential and drive value creation long-term.